209 related articles for article (PubMed ID: 33333417)
1. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
[TBL] [Abstract][Full Text] [Related]
3. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
[TBL] [Abstract][Full Text] [Related]
5. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
Tzanetakos D; Tzartos JS; Vakrakou AG; Breza M; Velonakis G; Stathopoulos P; Pantou E; Markakis I; Papadimitriou D; Karavasilis E; Toulas P; Evangelopoulos ΜE; Koutsis G; Anagnostouli M; Stefanis L; Kilidireas C
Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.
Jonas SN; Izbudak I; Frazier AA; Harrison DM
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1799-1805. PubMed ID: 30213813
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
[TBL] [Abstract][Full Text] [Related]
9. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
PLoS One; 2024; 19(5):e0300298. PubMed ID: 38809920
[TBL] [Abstract][Full Text] [Related]
10. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation.
Jakimovski D; Qureshi F; Ramanathan M; Jalaleddini K; Ghoreyshi A; Dwyer MG; Bergsland N; Weinstock-Guttman B; Zivadinov R
J Neurol Sci; 2024 Jun; 461():123055. PubMed ID: 38761669
[TBL] [Abstract][Full Text] [Related]
11. Postcontrast MRI of cranial meninges: leptomeningitis versus pachymeningitis.
Kioumehr F; Dadsetan MR; Feldman N; Mathison G; Moosavi H; Rooholamini SA; Verma RC
J Comput Assist Tomogr; 1995; 19(5):713-20. PubMed ID: 7560315
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis.
Makshakov G; Magonov E; Totolyan N; Nazarov V; Lapin S; Mazing A; Verbitskaya E; Trofimova T; Krasnov V; Shumilina M; Skoromets A; Evdoshenko E
Neurol Res Int; 2017; 2017():8652463. PubMed ID: 29291134
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
[TBL] [Abstract][Full Text] [Related]
14. Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosis.
Bonnan M; Money P; Desblache P; Marasescu R; Puvilland LM; Demasles S; Dahan C; Krim E; Tucholka A; Doyle S; Barroso B
Neurol Sci; 2021 May; 42(5):1959-1961. PubMed ID: 32995987
[TBL] [Abstract][Full Text] [Related]
15. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
[TBL] [Abstract][Full Text] [Related]
16. Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.
Zurawski J; Lassmann H; Bakshi R
JAMA Neurol; 2017 Jan; 74(1):100-109. PubMed ID: 27893883
[TBL] [Abstract][Full Text] [Related]
17. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.
Dahal S; Allette YM; Naunton K; Harrison DM
Mult Scler Relat Disord; 2024 Jan; 81():105344. PubMed ID: 38035495
[TBL] [Abstract][Full Text] [Related]
18. High-resolution contrast-enhanced vessel wall imaging in patients with suspected cerebral vasculitis: Prospective comparison of whole-brain 3D T1 SPACE versus 2D T1 black blood MRI at 3 Tesla.
Eiden S; Beck C; Venhoff N; Elsheikh S; Ihorst G; Urbach H; Meckel S
PLoS One; 2019; 14(3):e0213514. PubMed ID: 30849127
[TBL] [Abstract][Full Text] [Related]
19. No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.
Ighani M; Jonas S; Izbudak I; Choi S; Lema-Dopico A; Hua J; O'Connor EE; Harrison DM
Mult Scler; 2020 Feb; 26(2):165-176. PubMed ID: 31573837
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
